Physician profile
Bashar Pharoan
NPI 1285738633
$539.87
in general payments reported to CMS, 2019-2025
7 companies · $53.60 in 2025
The $53.60 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $15.89 · 2021: $177 · 2022: $13.58 · 2023: $56.98 · 2024: $36.44 · 2025: $53.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $147.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $279.22 | 2019-2024 | Sutab, Suflave |
| Smith+Nephew, INC. | $132.70 | 2019 | |
| Revance Therapeutics, INC. | $53.60 | 2025 | Daxxify |
| Pharmacosmos Therapeutics INC. | $24.84 | 2023 | Monoferric |
| Greer Laboratories, INC. | $18.48 | 2023 | Oralair |
| Astrazeneca Pharmaceuticals Lp | $17.45 | 2024 | Airsupra |
| Novo Nordisk INC | $13.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bashar Pharoan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.